Sign in

    John Wendell

    Research Analyst at JPC Partners

    John Wendell is a Research Analyst at JPC Partners focusing on equity research and financial analysis, with expertise in evaluating public companies. He has covered firms such as Daxor, participating in earnings calls and providing detailed Q&A analyses to inform investor decisions. Wendell began his professional career at JPC Partners, where he conducted company-specific equity research and performance evaluation. His professional credentials and securities licenses are not publicly listed, and there is currently no record of notable industry rankings or recognition.

    John Wendell's questions to DAXOR (DXR) leadership

    John Wendell's questions to DAXOR (DXR) leadership • Q4 2022

    Question

    John Wendell commented on the stock's underperformance relative to the company's progress and asked about the potential gross dollar value of a rumored U.S. Army order for 2,000 portable BVA devices.

    Answer

    CEO Michael Feldschuh addressed the stock price by stating management's focus is on creating long-term fundamental value through operational execution, which he believes will ultimately be reflected in the share price. Regarding the U.S. Army, he clarified that while Daxor is eligible for Phase 3 contracting, he could not comment on the size or value of any potential orders as that information is not public.

    Ask Fintool Equity Research AI